uSafeUS+ App Pilot Testing

May 14, 2026 updated by: University of Florida

Expanding the uSafeUS Mobile App to Reduce Alcohol-Involved Sexual Assault on College Campuses

The purpose of this study is to test the feasibility and acceptability of an innovative mobile application (uSafeUS+) to reduce college student drinking and sexual assault (SA) risk in real time. Following an initial period of app development, this study will use a pilot 3-arm randomized controlled trial (N = 90; 30/arm) to examine the acceptability, feasibility, and initial evidence of efficacy of the novel, expanded uSafeUS+ app, relative to the existing SA-only focused uSafeUS app (already in use on 24 college campuses), and an assessment-only control condition.

Specifically, the investigators aim to answer the following research questions:

  1. Do students like the app (overall and specific features)?
  2. How frequently do students use the app within the 1-month exposure period?
  3. What barriers and facilitators impact app use?
  4. Is there evidence of increased use of protective behaviors on drinking days and over time?
  5. Is there evidence of decreased drinking (amount, frequency) or SA risk on drinking days and over time?

Participants will complete:

  • A baseline assessment
  • A 1-month app exposure period with daily surveys about app use on the weekends
  • Follow-up surveys at 1- and 2-months post-intervention.

Study Overview

Status

Not yet recruiting

Detailed Description

Over 75% of campus sexual assaults involve alcohol, yet existing campus alcohol and SA prevention efforts designed for universal delivery are often siloed and limited in their ability to provide students with in-the-moment assistance to reduce risk. Smartphone apps are an integral part of college student life and are increasingly used to engage students in real-time alcohol prevention; however, none have integrated alcohol and sexual assault prevention into a single cross-cutting tool. This study addresses this gap by expanding a promising campus sexual assault prevention and response app (uSafeUS®) to include evidence-based alcohol harm reduction tools and real-time messaging to support students' use of protective behavioral strategies (PBS) in the moments when they most need them. The uSafeUS app, currently in use on 24 US college campuses, utilizes sexual assault PBS (e.g., sharing current locations and an expected return home time with trusted peers) as the primary risk reduction mechanism for students to use in social contexts where alcohol is present, yet none of the existing features directly address alcohol consumption. This project will leverage the existing uSafeUS infrastructure and a proven user-centered development process to expand app features to include an interactive drink tracker and personalized feedback messaging to reduce alcohol consumption and increase PBS use (uSafeUS+).

Following app development, the investigators will conduct a 3-arm pilot randomized controlled trial (N = 90) using an intensive longitudinal design to test uSafeUS+, relative to active (uSafeUS) and assessment-only control groups. Long term, uSafeUS+ is expected to reduce drinking outcomes and SA risk at 3-month follow-up by increasing PBS use and decreasing the amount students drink on days when students use PBS app features. This study will establish the feasibility and acceptability of uSafeUS+ and our proposed event-level evaluation approach, which is innovative and necessary to examine both between-group differences in behavioral outcomes over time and within-person variability in app feature use, acceptability, and behavioral outcomes across app use days, relative to non-app use days.

Specifically, the investigators will examine: a) app evaluability and evaluation plan feasibility using enrollment, retention, compliance, and app use data; b) overall acceptability of the app and evaluation procedures, including event-level variability in app acceptability during a 1-month app exposure period; c) psychometric properties of evaluation instruments; and d) preliminary effect sizes of app impacts on drinking and PBS use at the event level (via weekend daily diaries; uSafeUS+ vs. uSafeUS), and SA risk outcomes over time (1- and 2-month follow up; uSafeUS+ vs. uSafeUS + assessment-only control).

Participants will complete a baseline survey, which will determine participant eligibility, randomly assign students to conditions, and assess prior drinking behaviors, protective behavior use, and sexual assault experiences. Students in the uSafeUS+ or uSafeUS groups will be trained in using their assigned app and the daily survey protocols, followed by a 1-month app exposure period with integrated weekend daily diary assessments of event-level app feature acceptability, use context (where they were, who they were with), and outcomes (e.g., daily drinking, protective behavior use). The investigators will also passively collect embedded metadata on daily app usage. All students, regardless of group assignment, will complete 1- and 2-month drinking and SA risk surveys.

Study Type

Interventional

Enrollment (Estimated)

90

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Florida
      • Gainesville, Florida, United States, 32611
        • University of Florida
        • Contact:
        • Contact:
        • Principal Investigator:
          • Nichole Scaglione, PhD
    • New Hampshire
      • Durham, New Hampshire, United States, 03824
        • University of New Hampshire
        • Contact:
        • Principal Investigator:
          • Sharyn Potter, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Participants must be between the ages of 18 and 25 years old;
  • Currently enrolled as a residential undergraduate student at a participating university;
  • Intend to reside on or near (in the same town) campus over the two-month study period
  • Own a smartphone/mobile device;
  • Have consumed at least one alcoholic beverage per week or engaged in dating or social behaviors where alcohol is present at least once a week over the past 30 days;
  • Intend to drink or go out at the same frequency (at least weekly) over the two-month study period

Exclusion Criteria:

  • Unable or unwilling to provide informed consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: uSafeUS+
uSafeUS app with alcohol content
uSafeUS app
Other Names:
  • uSafeUS
Active Comparator: uSafeUS
Current UsafeUS app (no alcohol content)
uSafeUS app
No Intervention: assessment only (control)
Control

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Enrollment Rate
Time Frame: Baseline
The proportion of eligible participants (based on screening completion) who formally enroll in the study and complete baseline procedures.
Baseline
Retention from enrollment to 1-month follow up.
Time Frame: 1-month follow-up
Retention from enrollment to 1-month follow-up will be defined as the proportion of enrolled participants who complete the 1-month follow-up assessment.
1-month follow-up
Retention from enrollment to 2-month follow up.
Time Frame: 2-month follow up
Retention from enrollment to 2-month follow-up will be defined as the proportion of enrolled participants who complete the 2-month follow-up assessment.
2-month follow up
Daily Protocol Compliance
Time Frame: 1-month (assessed via daily surveys)
For all groups, the investigators will calculate the percentage of daily surveys that each participant completes.
1-month (assessed via daily surveys)
App use protocol compliance
Time Frame: 1-month (assessed via daily surveys)
The investigators will record the percentage of participants in uSafeUS+® and uSafeUS® groups who use the app at least weekly (minimum compliance)
1-month (assessed via daily surveys)
Overall App Usage
Time Frame: 1-month (assessed via daily surveys)
Number of days students use the app during the 1-month exposure period; this will be captured in the daily diaries for the uSafeUS+ and uSafeUS app groups.
1-month (assessed via daily surveys)
Overall App Acceptability
Time Frame: 1-month Follow Up (immediately post-intervention exposure)
Overall app feature acceptability will be assessed at the end of the exposure period using the System Usability Scale (SUS). At 1 month Follow-up, the investigators will assess acceptability via SUS total score.
1-month Follow Up (immediately post-intervention exposure)
Event- Level App Feature Acceptability
Time Frame: 1-month (assessed via daily surveys)
Within the daily surveys, feature acceptability assessments are adapted from standard app usability measures, such as the System Usability Scale (SUS; Brooke, 1996; Lewis, 2018) to assess the extent to which students found the features was easy to use. The investigators will report the aggregate mean (SD) across the features and app use period.
1-month (assessed via daily surveys)
Event- Level App Messaging Acceptability
Time Frame: 1-month (assessed via daily surveys)
Adapted from measures used in Dr. Suffoletto's text-based intervention work and Dr. Scaglione's tailored app-based intervention development, the investigators will assess whether the real-time and engagement message content felt personally relevant. Daily diary measures will adapt these items to ask specifically about any messages they received the day before. The investigators will report an aggregate mean (SD) across the app use period for the uSafeUS+ group.
1-month (assessed via daily surveys)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evaluation design acceptability
Time Frame: 2-month follow up
Proportion of participants reporting willingness to participate in a study like this again
2-month follow up
Sustained App Usage
Time Frame: 2-month follow-up
Proportion of uSafeUS+ and uSafeUS participants who endorse continued use of their assigned app in the month after the exposure period (report separately by condition).
2-month follow-up
Sustained App Acceptability
Time Frame: 2-month Follow up
Proportion of participants who indicate they would recommend the app to a friend one month after initial exposure.
2-month Follow up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

May 11, 2026

Primary Completion (Estimated)

August 31, 2026

Study Completion (Estimated)

August 31, 2026

Study Registration Dates

First Submitted

March 24, 2025

First Submitted That Met QC Criteria

April 24, 2026

First Posted (Actual)

April 29, 2026

Study Record Updates

Last Update Posted (Actual)

May 15, 2026

Last Update Submitted That Met QC Criteria

May 14, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 202501604
  • R34AA031379 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Deidentified data from the baseline, daily diary, and follow-up assessments will be shared per NIH requirements established through the negotiated data sharing agreement.

IPD Sharing Time Frame

Data will be shared via the NIAAA data archive starting 10/1/2026 for as long as NIH keeps the archive active.

IPD Sharing Access Criteria

Per the signed DSA, data and supporting will be available upon reasonable request via the NIAAA data archive.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Alcohol Consumption

Subscribe